1. Davey CH, Dawson-Rose CS, Nokes KM, Corless IB, et al.
   Sleep quality and disturbance during the COVID-19 pandemic among people with HIV globally: associations with social determinants of health.
   AIDS 2025.
   


2. Lam JO, Fan D, Pothamsetty N, Samiezade-Yazd Z, et al.
   Dementia incidence and prevalence in older adults with HIV: A 23-year retrospective cohort study.
   AIDS 2025.
   


3. Harrichandparsad R, Lustig G, Sviridchik V, Jule Z, et al.
   Cerebrospinal fluid proteomics reveals inflammatory activation in aneurysmal subarachnoid hemorrhage irrespective of HIV status.
   AIDS 2026.
   


4. Bolduc P.
   Recognizing the Critical Role of ID Physicians in Promoting HIV Syndemic Care in Health Professions Education.
   Clin Infect Dis 2026.
   


5. Balasubramanian R, Schnure M, Forster R, Hanage WP, et al.
   The Potential Effect of Ending CDC Funding for HIV Tests: A Modeling Study in 18 States.
   Clin Infect Dis 2026.
   


6. Scott SE, Barocas JA.
   Cutting federal funds for HIV testing means not Ending the HIV Epidemic.
   Clin Infect Dis 2026.
   


7. Solovyeva AV, Volchenkov GV, Ponomarenko OI, Kuznezova TA, et al.
   Implementing a Program of Comprehensive Tuberculosis Preventive Treatment: Safety, Effectiveness, and Acceptability of Moxifloxacin or Bedaquiline Use for Contacts Exposed to Drug-Resistant Strains.
   Clin Infect Dis 2026.
   


8. Little JS, Edelstein GE, Swank Z, Choudhary MC, et al.
   Protracted SARS-CoV-2 Infection in B-cell Depleted Patients: Immunologic andiral Characteristics and Response to Dual and Extended Antiviral Therapy.
   Clin Infect Dis 2025.
   


9. Swartwood NA, Cohen T, Marks SM, Hill AN, et al.
   Effects of the COVID-19 pandemic on TB outcomes in the United States: a Bayesian analysis.
   Clin Infect Dis 2025.
   


10. McCormack S, Dunn D, Kusemererwa S, Munseri P, et al.
    A comparison of F/TAF and F/TDF as HIV pre-exposure prophylaxis in a predominantly cisgender women population in East and South Africa: a randomised, factorial, non-inferiority trial.
    J Acquir Immune Defic Syndr 2026.
    


11. Silva MST, Torres TS, Teixeira SLM, Jalil EM, et al.
    HIV testing, incidence, and transmitted drug resistance among young cis men and non-binary persons who have sex with men.
    J Acquir Immune Defic Syndr 2026.
    


12. Shi F, Xia H, Li X, Olatosi B, et al.
    Long COVID Between People With and Without HIV: a Statewide Cohort Analysis.
    J Acquir Immune Defic Syndr 2026.
    


13. Vasquez E, Kuniholm MH, Appleton AA, Noor MI, et al.
    Cardiovascular Disease Risk and Falls in Men and Women Living with and Without HIV in MACS/WIHS Combined Cohort Study.
    J Acquir Immune Defic Syndr 2026.
    


14. Reis K, Lu X, Seepamore B, Wolf A, et al.
    Characterizing the dual burden of stigma in people with multidrug-resistant tuberculosis (MDR-TB) and HIV co-infection in South Africa: A mixed methods, prospective cohort study.
    J Acquir Immune Defic Syndr 2026.
    


15. Kalichman SC, Kalichman MO, Holt J, Stearns C, et al.
    Dose Determination Trial for Evidence-Based Behavioral Counseling to Improve.
    J Acquir Immune Defic Syndr 2026.
    


16. Johnson K, Billock R, Hallmark C, France AM, et al.
    National HIV Molecular Cluster Detection Supports Local Cluster Detection.
    J Acquir Immune Defic Syndr 2026.
    


17. Ekii OA, Kibengo FM, Samson O, Kizito K, et al.
    High HIV incidence among HIV infected BUT undetected individuals seeking HIV voluntary counselling and testing services in the greater Masaka Region in Uganda.
    J Acquir Immune Defic Syndr 2026.
    


18. Buzibye A, Hoke A, Bollinger RC, Omali D, et al.
    Letter to the editor: Mitochondrial DNA patterns among individuals living with HIV-1 on dolutegravir with hyperglycemia.
    J Acquir Immune Defic Syndr 2026.
    


19. Ripamonti E, Ma Q, Umlauf A, Letendre S, et al.
    Neurocognitive performance and depressive mood in people with HIV: The role of prescription opioids use.
    J Acquir Immune Defic Syndr 2026.
    


20. Routy JP, Isnard S.
    Increasing handgrip strength to combat frailty in HIV: Linking immune exhaustion to a bone health indicator.
    J Infect Dis 2026.
    


21. Zhang X.
    When PD-1 Meets Plaque: Making CD8 Senescence Signals Clinically Actionable in Treated HIV.
    J Infect Dis 2026.
    


22. Freeman ML, Fitzgerald W, Clagett BM, O'Hare KA, et al.
    Frailty in People with HIV is Linked to Inflammation, Bone Health, and T cell Exhaustion.
    J Infect Dis 2026.
    


23. Awada A, Tough RH, Fellay J, McLaren PJ, et al.
    Multi-ancestry GWAS identifies variants in a zinc finger gene cluster as novel regulators of HIV control.
    J Infect Dis 2026.
    


24. da Silva FC, Yokoya K, Hussain R, Kamuyu G, et al.
    Influence of Chlamydia trachomatis sequence variation on Pgp3 antigenicity.
    J Infect Dis 2026.
    


25. Endrias K, Sonawane S, Easley KA, Ukhueduan B, et al.
    Limited sex-based differences in viral outcomes of ART-treated SIV/SHIV infection.
    J Infect Dis 2026.
    


26. Donenberg GR, Eisinger RW.
    Future Directions for NIH HIV Research: A Look Ahead to 2026.
    J Infect Dis 2026.
    


27. Gianella S, Lauring A, Paredes R, Croda J, et al.
    Implementation Does Not Occur in a Vacuum: Sustaining a Comprehensive and Global Vision for HIV Research.
    J Infect Dis 2026.
    


28. Khetan P, Patel K, Yu W, Szewczyk J, et al.
    Dynamics of Intact and Defective HIV-1 Proviruses during Decades of Suppressive Antiretroviral Treatment in Young Adults with Perinatal HIV-1.
    J Infect Dis 2026.
    


29. Chandasana H, Buchanan AM, Henegar CA, McKenna M, et al.
    Model-informed Dolutegravir Dose Selection in Pediatrics With First-generation INSTI Resistance.
    Pediatr Infect Dis J 2026.
    


30. Bannard O, Howarth MR.
    A double helix twist in HIV vaccine design.
    Science 2026;391:553-554.
    


31. Romanov A, Knappe GA, Ronsard L, Cottrell CA, et al.
    DNA origami vaccines program antigen-focused germinal centers.
    Science 2026;391:eadx6291.
    

Display articles in

• Abstract format